Jeffrey E. Poiley
Impact in
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Inflammatory mediators and NSAID effects 4
-
- Osteoarthritis Treatment and Mechanisms 2
- Rheumatoid Arthritis Research and Therapies 2
- Co-authors
- Sergio Gutiérrez‐Ureña (2 shared papers)Alan Kivitz (2 shared papers)Jay Garg (2 shared papers)Mark C. Genovese (2 shared papers)Rita M. Kristy (1 shared paper)Alexandra Steinberg (1 shared paper)Charles S. Davis (1 shared paper)Charles A. McWherter (1 shared paper)
- Journals
- The American Journal of Medicine (3 papers)Arthritis & Rheumatology (2 papers)Rheumatology and Therapy (1 paper)Seminars in Arthritis and Rheumatism (1 paper)Data Archiving and Networked Services (DANS) (1 paper)
- Partner nations
- United StatesMexicoBelgium
In The Last Decade
Jeffrey E. Poiley
10 papers receiving 245 citations
Peers
Comparison fields: 5 of 64
- Rheumatology 141
- Nephrology 58
- Hematology 35
- Genetics 33
- Pharmacology 42
Countries citing papers authored by Jeffrey E. Poiley
This map shows the geographic impact of Jeffrey E. Poiley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey E. Poiley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey E. Poiley more than expected).
Fields of papers citing papers by Jeffrey E. Poiley
This network shows the impact of papers produced by Jeffrey E. Poiley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey E. Poiley. The network helps show where Jeffrey E. Poiley may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey E. Poiley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 87 | |
| 2 | 2016 | 61 | |
| 3 | 1989 | 42 | |
| 4 | 1974 | 23 | |
| 5 | 1987 | 19 | |
| 6 | 2019 | 12 | |
| 7 | 1986 | 7 | |
| 8 | 1987 | 5 | |
| 9 | Oskira-3: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To a Tumor Necrosis Factor-alpha Antagonist | 2013 | 1 |
| 10 | Rapid and consistent effect of risedronate on vertebral fracture risk reduction in elderly postmenopausal women | 2000 | 1 |
About Jeffrey E. Poiley
Jeffrey E. Poiley is a scholar working on Pharmacology, Rheumatology, Oncology, Analytical Chemistry and Surgery, having authored 10 papers that have together received 258 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Analytical Methods in Pharmaceuticals (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Cardiac Imaging and Diagnostics (1 paper), Hermeneutics and Narrative Identity (1 paper), Bone health and osteoporosis research (1 paper) and Bone health and treatments (1 paper). The work is most often cited by research in Rheumatology (141 citations), Nephrology (58 citations), Hematology (35 citations), Genetics (33 citations) and Pharmacology (42 citations). Jeffrey E. Poiley has collaborated with scholars based in United States, Mexico and Belgium. Frequent co-authors include Sergio Gutiérrez‐Ureña, Alan Kivitz, Jay Garg, Mark C. Genovese, Rita M. Kristy, Alexandra Steinberg, Charles S. Davis, Charles A. McWherter, Robert L. Martin and Pol Boudes. Their work appears in journals such as The American Journal of Medicine, Arthritis & Rheumatology, Rheumatology and Therapy, Seminars in Arthritis and Rheumatism and Data Archiving and Networked Services (DANS).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.